Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Immunoglobulin G
81%
B Cell
65%
Immunoglobulin G Antibody
64%
Plasmacytoid Dendritic Cell
56%
Human Immunodeficiency Virus
51%
COVID-19
48%
Immunogenicity
48%
Follicular B Helper T Cells
35%
Human Immunodeficiency Virus Infection
30%
Antigen Specificity
30%
Memory B Cell
29%
Isotype
29%
Omicron Coronavirus Variant
27%
Bioleaching
24%
Biofilm
24%
Otitis Media
24%
Therapeutic Antibodies
24%
Tetanus Vaccine
24%
Haemophilus
24%
Influenza
24%
Epitope Mapping
24%
RNA Sequence
24%
Immunoglobulin G2
22%
Antibody Response
22%
Plasmablast
18%
Immunoglobulin M
14%
Virus
14%
Nontypeable Haemophilus Influenzae
13%
Intravenous Immunoglobulin
13%
Immunoglobulin G1
11%
Neutralizing Antibody
10%
B Lymphocyte Subpopulation
10%
Neutralization
10%
Phagocytosis
10%
Spike
10%
Blood Plasma
8%
B-Cell Receptor
8%
Immune Response
8%
Mouse Model
8%
Antibody Secreting Cell
8%
Colony-Forming Unit
8%
Copy Number Variation
8%
Immunoglobulin D
7%
Paratope
6%
Cell Clone
6%
Amino Acid
6%
P24 Capsid Protein
6%
Epitope
6%
T Cell Subset
6%
Medicine and Dentistry
Diseases
52%
Nuclear RNA
48%
Hepatocyte
48%
Chronic Liver Disease
48%
RNA Sequence
48%
Hepatocellular Carcinoma
30%
COVID-19 Vaccine
24%
COVID-19
24%
Liver Cancer
14%
Carcinogenesis
14%
Tumor Microenvironment
14%
Cancer Risk
14%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Transcriptome
8%
Gene Expression
8%
Liver Disease
8%
Liver Carcinogenesis
8%
COVID-19 Vaccination
6%
Copy Number Variation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
56%
Messenger RNA
48%
Diseases
32%
COVID-19 Vaccine
24%
Neutralizing Antibody
24%
Chronic Liver Disease
24%
RNA-Sequencing
24%
SARS Coronavirus
24%
Liver Cell Carcinoma
24%
Immunoglobulin
24%
Adverse Event
12%
Uranium 234
12%
mRNA Vaccine
12%
Tumor Microenvironment
8%
Coronavirinae
8%
Liver Cancer
8%
Mouse Model
8%
Clinical Trial
8%
Infection
8%
Liver Carcinogenesis
8%
Carcinogenesis
8%
Liver Disease
8%
Transcriptome
8%